Body mass changes during pregnancy and concentration of insulin and neuropeptide Y in women with regard to the BMI;Zmiany masy ciala podczas ciazy oraz steżenieinsuliny i neuropeptydu Y u kobiet cieżarnychw zalezności od BMI

Ginekologia Polska

Volumn 82, Issue 12, 2011, Pages 892-899

  Estemberg, Dorota ^a   Sikora Szubert, Anita ^a   Kowalska Koprek, Urszula ^a   Berner Trabska, Marlena ^a   Brzozowska, Maria ^a   Jacek, Pasiński ^a   Świerczewski, Arkadiusz ^a   Karowicz Bilińska, Agata ^a  

^a Klinika Patologii Ciazy   (Poland)

Author keywords

Insulin; Neuropeptide Y; Obesity; Pregnancy

Indexed keywords

INSULIN; NEUROPEPTIDE Y;

ADULT; ARTICLE; BLOOD; BODY CONSTITUTION; BODY MASS; COMPARATIVE STUDY; FEMALE; HIGH RISK PREGNANCY; HUMAN; METHODOLOGY; OBESITY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; REFERENCE VALUE; RISK FACTOR; WOMEN'S HEALTH;

ADULT; BODY CONSTITUTION; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; NEUROPEPTIDE Y; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTERS; PREGNANCY, HIGH-RISK; PRENATAL CARE; REFERENCE VALUES; RISK FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84859390848     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Catalano P, Mouzon S.H.-D. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011, 204, 479-487.
2. D'Auria J. Weighing in: prevention of childhood overweight and obesity.J Pediatr Health Care. 2011, 25,:26-30.
3. Ismail-Beigi F, Catalano P, Hanson R. Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult. Am J Physiol Endocrinol Metab. 2006, 291, 439-440.
4. Zhan C, Rexrode K, van Dam R, [et al.]. Abdominal obesity and the risk of all cause cardiovascular and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008, 117, 1658-1667.
5. Lim S, Choi S, Park Y, [et al.]. Visceral fatness an insulin sensitivity in women with a previous history of gestational diabetes mellitus. Diab Care. 2007, 30, 348-353.
6. Walker L, Freeland-Graves J, Milani T. Weight and behavioral and psychosocial factors among ethnically diverse, low-income women after childbirth: II. Trends and correlates. Women Health. 2004, 40, 19-34.
7. Nohr E, Vaeth M, Baker J, [et al.]. Combined associations of prepregnancy body mass index and gestational weight gain with the outcome of pregnancy. Am J Clin Nutr. 2008, 87, 1750- 1759.
8. Davis C, Curtis C, Levitan R, [et al.]. Evidence that 'food addiction' is a valid phenotype of obesity. Appetite. 2011, 57, 711-717.
9. Pietrobelli A, Tosi C, Olivieri F, [et al.]. From fatness to leaness: where did we go wrong? Int J Pediatr Obes. 2011, 6, 42-45.
10. Estemberg D, Kowalska-Koprek U, Brzozowska M, [i wsp.]. Ocena ste{ogonek}żenia leptyny oraz VEGF w zależności od masy ciała powyżej 20 tygodnia cia{ogonek}ży. Ginekol Pol. 2009, 80, 338-342.
11. Ilhan A, Rasul S, Dimitrov A, [et al.]. Plasma neuropeptide Y levels differ in distinct diabetic conditions. Neuropeptides. 2010, 44, 485-489.
12. Jansson N, Nilsfelt A, Gellerstedt M, [et al.]. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr. 2008, 87, 1743-1749.
13. Wolff S, Legarth J, Vangsgaard K, [i wsp.]. A randomized trial of the effects of dietary counseling on gestational weight gain and glucose metabolism in obese pregnant women. Int J Obes. 2008, 32, 495-501.
14. Jensen D, Ovesen P, Beck-Nielsen H, [et al.]. Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women. Diabetes Care. 2005, 28, 2118-2122.
15. Bartness T, Keen-Rhinehart E, Dailey M, Teubner B. Neural and hormonal control of food boarding. Am J Physiol Regul Integr Comp Physiol. 2011, 301, 641-655.
16. Zhang L, Bijker M, Herzog H. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol Ther. 2011, 131, 91-113.
17. Estemberg D, Kowalska-Koprek U, Brzozowska M, Karowicz-Bilińska A. Wzrost masy ciała a ryzyko nadciśnienia w cia{ogonek}ży. Ginekol Pol. 2008, 79, 616-620.
18. Thorsdottir I, Torfadottir J, Birgisdottir B, Geirsson R. Weight gain in women of normal weight before pregnancy: complications in pregnancy or delivery and birth outcome. Obstet Gynecol. 2002, 99, 799-806.
19. Abenhaim H, Kinch R, Morin L, [et al.]. Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes. Arch Gynecol Obstet. 2007, 275, 39-43.
20. Kiel D, Dodson E, Artal R, [et al.]. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007, 110, 752-758.
21. Nohr E, Vaeth M, Baker J, [et al.]. Combined associations of prepregnancy body mass index and gestational weight gain with the outcome of pregnancy. Am J Clin Nutr. 2008, 87, 1750- 1759.
22. Rooney B, Schauberger C, Mathiason M. Impact of perinatal weight change on long-term obesity and obesity-related illnesses. Obstet Gynecol. 2005, 106, 1349-1356.
23. Bodnar L, Catov J, Klebanoff M, [et al.]. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007, 18, 234-239.
24. Catalano P. Increasing maternal obesity and weight gain during pregnancy: the obstetrics problems of plenititude. Obstet Gynecol. 2007, 110, 743-474.
25. Stotland N, Hopkins L, Caughey A. Gestational weight gain, macrosomia, and risk of cesarean birth in nondiabetic nulliparas. Obstet Gynecol. 2004, 104, 671-677.
26. Robinson H, Tkatch S, Mayes D, [et al.]. Is maternal obesity a predictor of shoulder dystocia? Obstet Gynecol. 2003, 101, 24-27.
27. Weiss J, Malone F, Emig D, [et al.]. Obesity, obstetric complications and cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol. 2004, 190, 1091-1097.
28. Usha Kiran T, Hemmadi S, Bethel J, Evans J. Outcome of pregnancy in a woman with an increased body mass index. BJOG. 2005, 112, 768-772.
29. Simmons D. Diabetes and obesity in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011, 25, 25-36.
30. Ehrenberg H, Mercer B, Catalano P. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004, 191, 964-968.
31. Tanentsapf I, Heitmann B, Adegboye A. Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth. 2011, 11, 81-86.
32. Klenke U, Constantin S, Wray S. Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors. Endocrinology. 2010, 151, 2736-2746.
33. Macut D, Micić D. Leptin and human reproduction. Med Pregl. 1998, 51, 410-414.